Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | 2.59% | 282.27 | 1.4% | $841.66m | |
| AMGN | Amgen, Inc. | 1.08% | 220.86 | 1.3% | $515.75m | |
| CELG | Celgene Corp. | 0.00% | 110.02 | 1.3% | $466.76m | |
| GILD | Gilead Sciences, Inc. | 1.98% | 65.07 | 1.0% | $400.35m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.34% | 209.80 | 1.9% | $313.89m | |
| ILMN | Illumina, Inc. | 2.53% | 305.99 | 3.5% | $311.32m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.92% | 344.87 | 2.6% | $267.68m | |
| EXAS | EXACT Sciences Corp. | 3.55% | 82.05 | 24.0% | $209.78m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.34% | 108.37 | 2.0% | $179.80m | |
| SGEN | Seattle Genetics, Inc. | 1.29% | 114.75 | 6.1% | $136.96m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.71% | 75.04 | 4.3% | $123.64m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.05% | 97.46 | 14.6% | $115.38m | |
| A | Agilent Technologies, Inc. | 1.95% | 78.26 | 1.6% | $101.36m | |
| NBIX | Neurocrine Biosciences, Inc. | 2.89% | 113.05 | 5.0% | $90.40m | |
| BGNE | BeiGene Ltd. | 0.94% | 198.25 | 2.1% | $88.64m |
Company Profile
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.